Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7.23M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
27.6M
-
Shares change
-
+1.05M
-
Total reported value, excl. options
-
$150M
-
Value change
-
+$4.15M
-
Number of buys
-
34
-
Number of sells
-
-37
-
Price
-
$5.43
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2021
86 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q2 2021.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.6M shares
.
Largest 10 shareholders include Bellevue Group AG (4.53M shares), BlackRock Inc. (2.6M shares), Logos Global Management LP (2.3M shares), FRANKLIN RESOURCES INC (2.28M shares), VANGUARD GROUP INC (1.9M shares), MORGAN STANLEY (1.58M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.41M shares), Prosight Management, LP (1.02M shares), MILLENNIUM MANAGEMENT LLC (801K shares), and DEUTSCHE BANK AG\ (792K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.